noticeable drift or fluctuation in the baseline of chromatograms can indicate carryover from previous injections.

Unexpected Peaks: The appearance of peaks in chromatograms corresponding to analytes not present in the sample being tested may suggest contamination from prior runs.

Repetitive Quality Control Failures: Increased frequency of out-of-specification (OOS) results in quality control checks can signal carryover issues that need investigation.

Lab Staff Reports: Technicians may report observations of residual material or dye from previous runs remaining in the sample vials or injection ports.

These symptoms require immediate attention to prevent further compromise of analytical integrity and compliance with Good Manufacturing Practices (GMP).

Likely Causes (by category)

To effectively address the issue of autosampler carryover, it is essential first to categorize the potential causes. These can be divided into five key categories—Materials, Method, Machine, Man, and Measurement:

• Materials: The type of samples, solvents, or reagents used may interact chemically or physically, leading to adsorption or carryover. For instance, viscous samples or those with a high protein content are notorious for causing carryover.
• Method: Analytical methods lacking sufficient wash steps or those that do not account for carryover in the method validation may be primed for failure. Insufficient flushing between samples can exacerbate this issue.
• Machine: Maintenance activities that do not adequately restore cleaning protocols or that result in mechanical wear leading to apex contamination can introduce carryover.
• Man: Human error, such as incorrect sample preparation or improper maintenance procedures, can lead to operational failures.
• Measurement: Inadequate sampling or measuring practices, including improper calibration of the autosampler, can misrepresent the results due to carryover.

Immediate Containment Actions (first 60 minutes)

In the event of identified carryover issues, quick containment actions are critical. Below is a framework of immediate actions to execute within the first 60 minutes:

1. Cease Testing: Stop any ongoing analysis where carryover is suspected to prevent further contamination of results.
2. Notify Stakeholders: Inform relevant personnel such as laboratory management and quality assurance immediately to initiate a coordinated response.
3. Document Observations: Record observations of the symptoms noticed, including chromatograms and sample details, to provide evidence for investigation.
4. Perform Immediate Cleaning: Conduct a thorough cleaning of the autosampler, injection port, and surrounding areas to eliminate any residual contaminants.
5. Re-evaluate Sample Preparation: Review the sample preparation processes to identify any lapses that could have contributed to carryover.

Implementing these actions swiftly is essential for mitigating immediate risks and establishing a foundation for further investigation.

Investigation Workflow (data to collect + how to interpret)

Following containment, an investigation workflow must be established to identify the root cause of the carryover issue. The following steps should be undertaken:

• Data Collection: Collect all relevant data, including chromatograms, logs from the autosampler, maintenance records, method documentation, and any previous incident reports related to carryover.
• Sample Integrity Check: Evaluate sample integrity by re-running tests on known clean samples to assess whether carryover persists.
• Operator Interviews: Conduct interviews or discussions with operators and technicians to garner insights regarding procedures before and after the preventive maintenance.
• Calibration and Repair Records: Review calibration records to ensure all equipment has been calibrated correctly prior to use.
• Histories of Previous Failures: Assess any previous occurrences of carryover and their resolutions to identify any recurring patterns.

The collected data should be scrutinized to identify trends, anomalies, or contributing factors that may elucidate the root cause of the carryover.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Employing structured root cause analysis tools is fundamental to effectively resolving the issue of autosampler carryover. The following methodologies can be utilized:

Tool	Description	When to Use
5-Why Analysis	A questioning technique that involves asking “why” multiple times until the root cause is determined.	Best used when the issue seems relatively straightforward or where there is a single observable outcome.
Fishbone Diagram	A visual tool that categorizes potential causes of a problem and shows relationships.	Effective for complex issues involving multiple factors from different categories like People, Processes, and Machines.
Fault Tree Analysis	A top-down approach that uses logic diagrams to map out the pathways of failure.	Useful in understanding systems of interactions and complex failures, particularly in automated systems.

Choosing the appropriate tool will depend on the specifics of the situation and the resources available. A combination of these methods may also yield the best results in complex scenarios.

CAPA Strategy (correction, corrective action, preventive action)

Once the root cause has been identified, a Corrective and Preventive Action (CAPA) strategy must be implemented. The strategy comprises three key components:

• Correction: Immediately address the identified causes of carryover. This may include recalibrating the autosampler, adjusting cleaning procedures, or modifying sample preparation protocols.
• Corrective Action: Develop and implement actions that prevent the recurrence of the issue. This may involve enhancing training for staff on proper maintenance or altering the method to include more thorough cleaning steps.
• Preventive Action: Proactively establish monitoring measures and controls that will prevent similar incidents, such as implementing routine checks of carryover rates or adjusting the method validation process.

Documentation of all CAPA activities is essential to ensure compliance with regulatory standards and provide evidence during inspections.

Related Reads

• Unplanned Downtime and Bad Readings? Troubleshooting Solutions for Pharma Equipment and Instruments

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

Implementing a robust control strategy is critical to maintaining product integrity and ensuring that carryover issues do not recur. Key components of this strategy include:

• Statistical Process Control (SPC): Use SPC techniques to monitor the lifecycle of autosampler performance, looking specifically for trends that indicate potential carryover.
• Routine Sampling: Regularly sample and test known standards to identify any inconsistencies that could suggest carryover during routine analytical runs.
• Automated Alarms: Implement automated alerts for operators when unusual carryover patterns are detected during analyses, allowing for prompt responsiveness.
• Verification Procedures: Regularly verify the efficiency of cleaning procedures and maintenance activities to ensure they remain effective over time.

By adopting these measures, laboratories can enhance the reliability of analytical results and demonstrate a commitment to quality and compliance.

Validation / Re-qualification / Change Control impact (when needed)

Following any corrective actions related to the identified carryover, validation, re-qualification, and change control must be revisited. Key considerations include:

• Validation of Changes: Any changes made to the autosampler’s method, cleaning procedures, or equipment configurations must undergo validation to ensure they effectively mitigate carryover risks.
• Re-qualification Process: The autosampler may need to be requalified to verify it meets the required specifications for performance.
• Change Control Review: Review and document any changes made during the CAPA process to support compliance with GMP regulations and facilitate inspections.

This rigorous approach ensures that all adjustments made in response to carryover incidents are appropriately evaluated and documented.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

Being inspection-ready is vital for demonstrating compliance with FDA, EMA, and MHRA regulations. The following documentation and evidence should be prepared:

• Maintenance Logs: Maintain accurate records of all maintenance and preventive measures performed on the autosampler.
• Batch Documentation: Ensure batch records are complete, showcasing all factors involved in the testing process, including results and compliance with established methods.
• Deviation Reports: Record and document any deviations encountered during testing related to carryover, along with the investigations undertaken and the CAPAs implemented.
• Training Records: Provide evidence of training for all personnel involved with equipment operation and maintenance concerning new procedures following CAPA implementation.

Compiling these documents serves as evidence of due diligence, continuous improvement, and proactive problem-solving measures that can significantly mitigate compliance risks.

FAQs

What is autosampler carryover?

Autosampler carryover occurs when residual sample material from a previous injection contaminates the subsequent sample, leading to inaccurate analytical results.

What causes autosampler carryover?

Carryover can be attributed to issues with sample materials, method procedures, maintenance practices, or human error.

How can I detect carryover in my samples?

Monitoring chromatic baseline stability and reviewing for unexpected peaks can indicate potential carryover in analytical results.

What immediate actions should I take when I suspect carryover?

Cease testing, notify stakeholders, document findings, clean the autosampler, and evaluate sample preparation processes immediately.

Which root cause analysis tools are effective for this problem?

Effective tools include the 5-Why analysis, Fishbone diagrams, and Fault Tree analysis, chosen based on the complexity of the incidents.

What documentation is necessary during a CAPA process?

Necessary documentation includes maintenance logs, deviation reports, training records, and batch documentation demonstrating compliance and investigation outcomes.

How often should I conduct preventive maintenance on my autosampler?

Preventive maintenance should be conducted according to the manufacturer’s recommendations and any identified observations from previous carryover incidents.

What are regulatory expectations regarding carryover?

Regulatory agencies like the FDA, EMA, and MHRA expect companies to monitor, investigate, and mitigate carryover risks as part of their quality assurance processes.